INCY logo

Incyte (INCY) Company Overview

Profile

Full Name:

Incyte Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 4, 1993

Indexes:

Description:

Incyte Corporation is a biopharmaceutical company. The company offers the drug JAKAFI for the treatment of myelofibrosis and polycythemia, as well as Iclusig, a kinase inhibitor for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Its clinical products include ruxolitinib, a Phase III drug for steroid-refractory chronic graft-versus-host disease (GVHD); and Phase II drug for the treatment of essential thrombocythemia and refractory myelofibrosis. In addition, the company is developing itacitinib, which is in Phase III clinical trials for the treatment of naïve chronic GVHD; and pemigatinib, which is in Phase II clinical trials for the treatment of bladder cancer, cholangiocarcinoma, 8p11 myeloproliferative syndrome, and tumor-agnostic syndrome. The company is also involved in the development of Parsaclisib, which is in Phase II clinical trials for follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma. The company is developing INCMGA0012, which is in Phase II clinical trials for high-grade endometrial MSI cancer, Merkel

Key Details

Price

$70.79

Annual Revenue

$4.24 B(+14.76% YoY)

Annual EPS

$0.15(-94.34% YoY)

PE Ratio

262.19

Beta

0.50

Events Calendar

Earnings

Next earnings date:

Apr 30, 2025

Recent quarterly earnings:

Feb 10, 2025

Recent annual earnings:

Feb 10, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 1, 2000

Analyst ratings

Recent major analysts updates

Feb 11, 25 RBC Capital
Sector Perform
Feb 11, 25 JMP Securities
Market Perform
Feb 11, 25 Citigroup
Buy
Feb 10, 25 Stifel
Hold
Jan 23, 25 RBC Capital
Sector Perform
Jan 14, 25 JMP Securities
Market Perform
Jan 10, 25 Cantor Fitzgerald
Neutral
Dec 19, 24 Wells Fargo
Equal-Weight
Nov 19, 24 RBC Capital
Sector Perform
Nov 19, 24 Cantor Fitzgerald
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Incyte?
  • Does Incyte pay dividends?
  • What sector is Incyte in?
  • What industry is Incyte in?
  • What country is Incyte based in?
  • When did Incyte go public?
  • Is Incyte in the S&P 500?
  • Is Incyte in the NASDAQ 100?
  • Is Incyte in the Dow Jones?
  • When was Incyte's last earnings report?
  • When does Incyte report earnings?
  • Should I buy Incyte stock now?

What is the ticker symbol for Incyte?

The ticker symbol for Incyte is NASDAQ:INCY

Does Incyte pay dividends?

No, Incyte does not pay dividends

What sector is Incyte in?

Incyte is in the Healthcare sector

What industry is Incyte in?

Incyte is in the Biotechnology industry

What country is Incyte based in?

Incyte is headquartered in United States

When did Incyte go public?

Incyte's initial public offering (IPO) was on November 4, 1993

Is Incyte in the S&P 500?

Yes, Incyte is included in the S&P 500 index

Is Incyte in the NASDAQ 100?

No, Incyte is not included in the NASDAQ 100 index

Is Incyte in the Dow Jones?

No, Incyte is not included in the Dow Jones index

When was Incyte's last earnings report?

Incyte's most recent earnings report was on Feb 10, 2025

When does Incyte report earnings?

The next expected earnings date for Incyte is Apr 30, 2025

Should I buy Incyte stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions